Global Sleep Apnea Devices Market to expand with 10.6% CAGR through 2023

November 21, 2019


According to the research report titled ‘Global Sleep Apnea Devices Market - By Diagnostic Devices, By Therapeutic Devices, By End User, By Region, By Country (2018 Edition): Forecast to 2023- - By Diagnostic Devices (Polysomnography, Respiratory Polygraphs, Pulse Oximeter, Actigraphy), By Therapeutic Devices (CPAP, APAP, Bi-PAP, ASV, Facial Interfaces, Oral Appliances),By Region (N. America, Europe, APAC, ROW), By Country (U.S, Canada, Germany, Mexico, Germany, France, U.K, Japan, China, India, Australia, Brazil)’ available with Market Study Report LLC, the global sleep apnea devices market is expected to grow with a CAGR of 10.6% during the period of 2018-2023.
 

Growing occurrences of sleep related breathing ailments, coupled with increasing elderly and obese population are key factors driving the growth of  sleep apnea devices market. The market is said to further expand due to mounting cases of lifestyle related diseases, surging demand for non-invasive treatments and development of innovative medical products. Escalating healthcare expenditure in emerging economies will further augment the demand for sleep apnea devices.
 

Based on product type, sleep apnea devices market is categorized into diagnostic devices and therapeutic devices. Diagnostic devices segment is further divided into respiratory polygraphs, polysomnography, actigraphy devices, and pulse oximeter. While the therapeutic devices segment is fragmented into CPAP, Bi-PAP, ASV, APAP, oral appliances, and facial interfaces. According to the report, the diagnostic devices segment is anticipated to dominate sleep apnea devices market over the analysis period.
 

Considering the geographical landscapes, the global sleep apnea devices market is divided into regions namely, Europe, North America, Asia-Pacific, and rest of the world with primary focus on countries which include Germany, Canada, US, Mexico, France, Japan, China, UK, Australia, India, and Brazil.
 

Request sample copy of this Report@ https://www.marketstudyreport.com/request-a-sample/1228222/
 

The report cites that North America held the largest regional share of the global sleep apnea devices market in 2018. However, APAC region is expected to witness substantial growth during the forecast timeline, due to surging per capita expenditure on healthcare and presence of a large customer base in emerging countries like India and China.
 

The key players in sleep apnea devices market are Koninklijke Philips, ResMed, Fisher & Paykel Health, Compumedics, SomnoMed, Itamar Medical Ltd., Novasom, Whole You, Braebon Medical, and Lowenstein Medical.


Frequently Asked Questions (FAQ) :

Growing occurrences of sleep related breathing ailments, coupled with increasing elderly and obese population are key factors driving the growth of sleep apnea devices market. The market is said to further expand due to mounting cases of lifestyle related diseases, surging demand for non-invasive treatments and development of innovative medical products. Escalating healthcare expenditure in emerging economies will further augment the demand for sleep apnea devices.
Based on product type, the global sleep apnea devices market is categorized into diagnostic devices and therapeutic devices. Diagnostic devices segment is further divided into respiratory polygraphs, polysomnography, actigraphy devices, and pulse oximeter. Therapeutic devices segment is also fragmented into CPAP, Bi-PAP, ASV, APAP, oral appliances and facial interfaces. According to the research report, the diagnostic devices segment is anticipated to dominate the sleep apnea devices market in the upcoming years.
APAC region is expected to witness substantial growth during the forecast period, due to surging per capita expenditure on healthcare and presence of a large customer base in emerging countries like India and China.
The key players in sleep apnea devices market are Koninklijke Philips, ResMed, Fisher & Paykel Health, Compumedics, SomnoMed, Itamar Medical Ltd., Novasom, Whole You, Braebon Medical, and Lowenstein Medical.